Groowe Groowe / Newsroom / GNPX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

GNPX News

Genprex, Inc. Common Stock

Form 8-K

sec.gov
GNPX

Form 8-K

sec.gov
GNPX

Flagship Pioneering and Lean Business Services Company Announce Collaboration to Advance Healthcare Innovation and AI-Enabled Biomedical Research in Saudi Arabia

prnewswire.com
MRNA SANA FHTX GNPX LILA

Form 8-K

sec.gov
GNPX

Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer

prnewswire.com
GNPX

Form 8-K

sec.gov
GNPX

Genprex to Participate at BIO International Convention 2026

prnewswire.com
GNPX

Form 8-K

sec.gov
GNPX

Form 8-K

sec.gov
GNPX

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting

prnewswire.com
GNPX